Non Hodgkin Lymphoma Clinical Trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Summary

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug.

NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact [email protected], or if a patient, your nearest participating TAPUR site (see participating centers).

******************************************************************************************************************************************************************************

Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress.

******************************************************************************************************************************************************************************

View Full Description

Full Description

The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial that aims to describe the safety and efficacy of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer that has a potentially actionable genomic variant. TAPUR will study Food and Drug Administration (FDA)-approved targeted therapies that are contributed by collaborating pharmaceutical companies, catalogue the choice of molecular profiling test by clinical oncologists and develop hypotheses for additional clinical trials.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

12 years of age or older (*Restrictions apply. Not all therapies are available for patients <18)
Histologically-proven locally advanced or metastatic solid tumor, multiple myeloma or B cell non-Hodgkin lymphoma who is no longer benefiting from standard anti-cancer treatment or for whom, in the opinion of the treating physician, no such treatment is available or indicated
Performance status 0-2 (Per Eastern Cooperative Oncology Group (ECOG) criteria)

Patients must have acceptable organ function as defined below. However, as noted above, drug-specific inclusion/exclusion criteria specified in the protocol appendix for each agent will take precedence for this and all inclusion criteria:

Absolute neutrophil count ≥ 1.5 x 106/µl
Hemoglobin > 9.0 g/dl
Platelets > 75,000/µl
Total bilirubin < 2.0 mg/ dl, except in patients with Gilbert's Syndrome
Aspartate aminotransferase (AST) serum glutamic-oxaloacetic transaminase (SGOT) and alanine aminotransferase (ALT) serum glutamic-pyruvic transaminase (SGPT) < 2.5 x institutional upper limit of normal (ULN) (or < 5 x ULN in patients with known hepatic metastases)
Serum creatinine ≤ 1.5 × ULN or calculated or measured creatinine clearance ≥ 50 mL/min/1.73 m2
Patients must have disease that can be objectively measured by physicial or radiographic exam or evaluable disease (per RECIST v1.1 for solid tumor, Lugano criteria for non Hodgkin lymphoma or International Myeloma Working Group criteria for multiple myeloma), defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as ≥20 mm with conventional techniques or as ≥10 mm with spiral computed tomography (CT) scan, Magnetic Resonance Imaging (MRI), or a subcutaneous or superficial lesion that can be measured with calipers by clinical exam. For lymph nodes, the short axis must be ≥15 mm. Patients who have assessable disease by physical or radiographic examination but do not meet these definitions of measurable disease are eligible and will be considered to have evaluable disease. Patient's whose disease cannot be objectively measured by physical or radiographic examination (e.g., elevated serum tumor marker only, bone-only disease without an identifiable soft tissue component, or patients with only assessable non-measurable disease) are NOT eligible.
Results must be available from a genomic test or immunohistochemistry (IHC) test for protein expression performed in a Clinical Laboratory Improvement Amendments (CLIA)-certified and College of American Pathologists (CAP)-accredited or New York State accredited (for labs offering services to residents of NY) laboratory. Labs that have registered the test with the NIH Genetic Testing Registry or that provide a report that has been designated as optimized for TAPUR participation are preferred, but not required. The genomic or IHC test used to qualify a patient for participation in TAPUR may have been performed on any specimen of the patient's tumor obtained at any point during the patient's care at the discretion of the patient's treating physician. Genomic assays performed on cell-free DNA in plasma ("liquid biopsies") will also be acceptable if the genomic analysis is performed in a laboratory that meets the criteria described above.
Ability to understand and the willingness to sign a written informed consent/assent document.
Have a tumor genomic profile for which single agent treatment with one of the FDA approved targeted anti-cancer drugs included in this study has potential clinical benefit based on the criteria described in protocol.
For orally administered drugs, the patient must be able to swallow and tolerate oral medication and must have no known malabsorption syndrome.
Because of the risks of drug treatment to the developing fetus, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) for the duration of study participation, and for four months following completion of study therapy. Should a woman become pregnant or suspect she is pregnant while participating in this study or if she is the partner of a male participant in this study and becomes pregnant while he is participating in this study, she should inform her or her partner's treating physician immediately as well as her obstetrician. Female study patients who become pregnant must immediately discontinue treatment with any study therapy. Male patients should avoid impregnating a female partner. Male study patients, even if surgically sterilized, (i.e. post-vasectomy) must agree to one of the following: practice effective barrier contraception during the entire study treatment period and for a specified amount of time the last dose of study drug, or completely abstain from sexual intercourse.

Note: TAPUR does not explicitly exclude any type of solid tumor, but the patient must have measurable and evaluable disease per RECIST v1.1.

Exclusion Criteria:

Patients whose disease is not measurable or cannot be assessed by radiographic imaging or physical examination (e.g., elevated serum tumor marker only) are not eligible
Patients with primary brain tumors or leptomeningeal metastases are excluded.
Patients with previously treated brain metastases are eligible, provided that the patient has not experienced a seizure or had a clinically significant change in neurological status within the 3 months prior to registration. All patients with previously treated brain metastases must be clinically stable for at least 1 month after completion of treatment and off steroid treatment for one month prior to study enrollment.
Patients with known progressive brain metastases are eligible but additional eligibility criteria apply.

Note: there are additional exclusion criteria that may apply

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 2

Estimated Enrollment:

3641

Study ID:

NCT02693535

Recruitment Status:

Recruiting

Sponsor:

American Society of Clinical Oncology

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 112 Locations for this study

See Locations Near You

University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham Alabama, 35294, United States More Info
Susan Pruitt
Contact
205-975-7265
[email protected]
Eddy Yang, MD
Principal Investigator
Cancer Treatment Centers of America-Phoenix
Phoenix Arizona, 85338, United States More Info
Jessica Coats, MS, RN, CCRC
Contact
623-207-3899
[email protected]
Ashish Sangal, MD
Principal Investigator
Sutter Auburn
Auburn California, 95602, United States More Info
Kirsten Babski
Contact
916-878-4990
[email protected]
Sutter Alta Bates
Berkeley California, 94705, United States More Info
Vivian Leong, RN
Contact
510-204-3428
[email protected]
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
Los Angeles California, 90025, United States More Info
Saba Mukarram
Contact
310-231-2181
[email protected]
Omid Hamid, MD
Principal Investigator
Kaiser Permanente - Oakland Medical Center
Oakland California, 94611, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Sutter Palo Alto Medical Foundation: Palo Alto
Palo Alto California, 94301, United States More Info
Kaiser Permanente - Roseville Medical Center
Roseville California, 95661, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Sutter Roseville
Roseville California, 95661, United States More Info
Kirsten Babski
Contact
916-878-4990
[email protected]
Kaiser Permanente - Sacramento Medical Center
Sacramento California, 95814, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Sutter Sacramento
Sacramento California, 95816, United States More Info
Isabel Rodrigues-Fong
Contact
916-454-6628
[email protected]
Kaiser Permanente - South San Francisco Medical Center
San Francisco California, 94080, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
California Pacific Medical Center Research Institute
San Francisco California, 94115, United States More Info
Deepti Behl, MD
Principal Investigator
Kaiser Permanente - San Francisco Medical Center
San Francisco California, 94115, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Sutter Cancer Research Consortium
San Francisco California, 94115, United States More Info
Laurel Brechtel
Contact
415-600-1654
[email protected]
Stacy D'Andre, MD
Principal Investigator
Kaiser Permanente - San Jose Medical Center
San Jose California, 95119, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Kaiser Permanente - San Leandro Medical Center
San Leandro California, 94577, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Kaiser Permanente - Santa Clara Medical Center
Santa Clara California, 95051, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Sutter Palo Alto Medical Foundation: Santa Cruz
Santa Cruz California, 95065, United States More Info
Sutter Palo Alto Medical Foundation: Fremont
Santa Cruz California, 99453, United States More Info
Sutter Palo Alto Medical Foundation: Sunnyvale
Sunnyvale California, 94086, United States More Info
Kaiser Permanente - Vallejo Medical Center
Vallejo California, 94589, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M. Suga, MD
Principal Investigator
Kaiser Permanente - Walnut Creek Medical Center
Walnut Creek California, 94596, United States More Info
Desiree Goldstein
Contact
[email protected]
Jennifer M Suga, MD
Principal Investigator
Saint Vincent's Medical Center (SVMC)
Bridgeport Connecticut, 06606, United States More Info
Wylie Hosmer, MD
Principal Investigator
Hartford Hospital
Hartford Connecticut, 06002, United States More Info
Midstate Medical Center (MSMC)
Meriden Connecticut, 06451, United States More Info
Wylie Hosmer, MD
Principal Investigator
The Hospital of Central Connecticut (HOCC) Cancer Center
New Britain Connecticut, 06053, United States More Info
Wylie Hosmer, MD
Principal Investigator
William W. Backus Hospital
Norwich Connecticut, 06360, United States More Info
Wylie Hosmer, MD
Principal Investigator
Charlotte Hungerford
Torrington Connecticut, 06790, United States More Info
Wylie Hosmer, MD
Principal Investigator
Windham Hospital (WH)
Willimantic Connecticut, 06226, United States More Info
Wylie Hosmer, MD
Principal Investigator
Holy Cross Hospital
Fort Lauderdale Florida, 33308, United States More Info
Stephanie Couch
Contact
734-712-3671
[email protected]
Tareq Al Baghdadi, MD
Principal Investigator
Florida Cancer Specialists South / Sarah Cannon Research Institute
Fort Myers Florida, 33901, United States More Info
Fadi Kayali, MD
Principal Investigator
University of Florida Health
Gainesville Florida, 32610, United States More Info
Nghi Lam, MS
Contact
352-265-5329
[email protected]
Thomas George, MD
Principal Investigator
University of Miami Sylvester Comprehensive Cancer Center
Miami Florida, 33136, United States More Info
Carolina Troche, BS
Contact
305-243-1481
[email protected]
Carmen Calfa, MD
Principal Investigator
Florida Cancer Specialists North / Sarah Cannon Research Institute
Saint Petersburg Florida, 33705, United States More Info
David Wright, MD
Principal Investigator
Florida Cancer Specialists Panhandle / Sarah Cannon Research Institute
Tallahassee Florida, 32308, United States More Info
Viralkumar Bhanderi, MD
Principal Investigator
Florida Cancer Specialists East / Sarah Cannon Research Institute
West Palm Beach Florida, 33401, United States More Info
Shachar Peles, MD
Principal Investigator
Cancer Treatment Centers of America - Atlanta
Atlanta Georgia, 30265, United States More Info
Mittie Mitchell, RN
Contact
770-400-7194
[email protected]
Herbert L. Duvivier, MD
Principal Investigator
Emory University Winship Cancer Institute
Atlanta Georgia, 30322, United States More Info
Suzanne Scott
Contact
404-778-4083
[email protected]
Olatunji Alese, MD
Principal Investigator
Gynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research Pavilion
Savannah Georgia, 31405, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
Lewis Cancer & Research Pavilion at the Melanoma, Skin Cancer & Sarcoma Institute
Savannah Georgia, 31405, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
Lewis Cancer & Research Pavilion
Savannah Georgia, 31405, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
Summit Cancer Care
Savannah Georgia, 31405, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
The Queen's Medical Center (The University of Texas MD Anderson Cancer Center)
Honolulu Hawaii, 96813, United States More Info
Amanda Eckert, MPH
Contact
713-745-8074
[email protected]
Funda Meric-Bernstam, MD
Principal Investigator
Cancer Treatment Centers of America-Chicago
Chicago Illinois, 60099, United States More Info
Fola Arowora, MS, MPH
Contact
847-872-6434
[email protected]
Eugene Ahn, MD
Principal Investigator
Community Health Network (The University of Texas MD Anderson Cancer Center)
Indianapolis Indiana, 46250, United States More Info
Amanda Eckert, MPH
Contact
713-745-8074
[email protected]
Funda Meric-Bernstam, MD
Principal Investigator
Harold Alfond Center for Cancer Care
Augusta Maine, 04330, United States More Info
Sandra Neptune, BSN, RN
Contact
207-626-4811
[email protected]
Rachit Kumar, MD
Principal Investigator
Jackson Laboratory - Maine Cancer Genomics Initiative
Augusta Maine, 04330, United States More Info
Petra Helbig, CCRP
Contact
207-664-4659
[email protected]
Jens Rueter, MD
Principal Investigator
Waldo County General Hospital
Belfast Maine, 04915, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
SMHC Cancer Care and Blood Disorders -Biddeford
Biddeford Maine, 04005, United States More Info
Jen Dalton
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
Northern Light Cancer Care
Brewer Maine, 04412, United States More Info
Carla Mancini, MHA, BSN, RN
Contact
207-973-5581
[email protected]
Sarah Sinclair, MD
Principal Investigator
Raish Peavey Haskell Children's Cancer and Treatment Center
Brewer Maine, 04412, United States More Info
Carla C Mancini, RN, BSN, OCN
Contact
207-973-5581
[email protected]
Sarah Sinclair, MD
Principal Investigator
MaineHealth Cancer Care -Brunswick
Brunswick Maine, 04011, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
New England Cancer Specialist
Kennebunk Maine, 04043, United States More Info
Patricia C Collins
Contact
207-303-3422
[email protected]
Christian Thomas, MD
Principal Investigator
York Hopsital Oncology & Infusion Care in Kittery
Kittery Maine, 03904, United States More Info
Brenda i Kiberd, RN
Contact
207-361-6115
[email protected]
Marilyn McLaughlin, MD
Principal Investigator
Stephens Memorial Hospital
Norway Maine, 04268, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
Penobscot Bay Medical Center
Rockport Maine, 04856, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
SMHC Cancer Care and Blood Disorders -Sandford
Sanford Maine, 04073, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
Maine Children's Cancer Program
Scarborough Maine, 04074, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
Maine Medical Partner's Women's Health
Scarborough Maine, 04074, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
New England Cancer Specialist
Scarborough Maine, 04074, United States More Info
Patricia Collins, BA, CCRC
Contact
207-303-3422
[email protected]
Christian Thomas, MD
Principal Investigator
MaineHealth Cancer Care -South Portland
South Portland Maine, 04106, United States More Info
Jen Dalton, MHA, BSN, RN
Contact
207-294-8291
[email protected]
Roger Inhorn, MD
Principal Investigator
New England Cancer Specialist
Topsham Maine, 04086, United States More Info
Patricia C Collins, BA, CCRC
Contact
207-303-3422
[email protected]
Christian Thomas, MD
Principal Investigator
York Hospital Oncology & Infusion Care in Wells
Wells Maine, 04090, United States More Info
Brenda Kiberd, RN
Contact
207-361-6115
[email protected]
Marilyn McLaughlin, MD
Principal Investigator
York Hospital Oncology & Infusion Care in York
York Maine, 03909, United States More Info
Brenda i Kiberd, RN
Contact
207-361-6115
[email protected]
Marilyn McLaughlin, MD
Principal Investigator
University of Michigan
Ann Arbor Michigan, 48109, United States More Info
Cancer AnswerLine Nurses
Contact
800-865-1125
[email protected]
Elie Dib, MD
Principal Investigator
St. Joseph Mercy - Brighton
Brighton Michigan, 48114, United States More Info
Stephanie Couch, BS
Contact
734-712-7251
[email protected]
Elie Dib, MD
Principal Investigator
St. Joseph Mercy - Canton
Canton Michigan, 48188, United States More Info
Stephanie Couch, BS
Contact
734-712-7251
[email protected]
Elie Dib, MD
Principal Investigator
St. Joseph Mercy - Chelsea
Chelsea Michigan, 48118, United States More Info
Stephanie Couch
Contact
734-712-7251
[email protected]
Elie Dib, MD
Principal Investigator
Ascension St. John Hospital
Detroit Michigan, 48236, United States More Info
Stephanie Couch
Contact
734-712-3671
[email protected]
Elie Dib, MD
Principal Investigator
Genesys Hurley Cancer Institute
Grand Blanc Michigan, 48439, United States More Info
Stephanie Couch, BS
Contact
734-712-3671
[email protected]
Elie Dib, MD
Principal Investigator
Cancer Research Consortium of West Michigan
Grand Rapids Michigan, 49503, United States More Info
Connie Szczepanek, RN
Contact
616-391-1230
[email protected]
Kathleen J. Yost, MD
Principal Investigator
Ascension Borgess Cancer Center
Kalamazoo Michigan, 49009, United States More Info
Connie Szczepanek, RN
Contact
616-391-1230
[email protected]
Kathleen Yost, MD
Principal Investigator
Sparrow Hospital
Lansing Michigan, 48912, United States More Info
Stephanie Couch, BS
Contact
734-712-3671
[email protected]
Elie Dib, MD
Principal Investigator
St. Mary Mercy Hospital
Livonia Michigan, 48154, United States More Info
Stephanie Couch, BS
Contact
734-712-7251
[email protected]
Elie Dib, MD
Principal Investigator
St. Joseph Mercy Hospital Oakland
Pontiac Michigan, 48341, United States More Info
Stephanie Couch, BS
Contact
734-712-3671
[email protected]
Elie Dib, MD
Principal Investigator
Ascension St. Mary's Hospital
Saginaw Michigan, 48601, United States More Info
Ascension St. M Hospital, BS
Contact
734-712-3671
[email protected]
Elie Dib, MD
Principal Investigator
Michigan Cancer Research Consortium
Traverse City Michigan, 48341, United States More Info
Beth LaVasseur, RN, MS
Contact
734-712-7251
[email protected]
Contact
877-590-5995
Philip Stella, MD
Principal Investigator
St. John Macomb Oakland Hospital
Warren Michigan, 48093, United States More Info
Stephanie Couch, BS
Contact
734-712-3671
[email protected]
Elie Dib, MD
Principal Investigator
University of Nebraska Medical Center
Omaha Nebraska, 68198, United States More Info
Brandie Booker, RN, BSN, OCN
Contact
402-559-8197
[email protected]
Alissa Marr, MD
Principal Investigator
NH Oncology - Hematology, PA
Concord New Hampshire, 03103, United States More Info
Ali Fleury
Contact
603-314-6888
[email protected]
Douglas Weckstein, MD
Principal Investigator
Solinsky Center for Cancer Care
Manchester New Hampshire, 03103, United States More Info
Ali Fleury, BA, CCRP
Contact
603-314-6888
[email protected]
Douglas Weckstein, MD
Principal Investigator
New England Cancer Specialist
Portsmouth New Hampshire, 03801, United States More Info
Patricia C Collins, BA, CCRC
Contact
207-303-3422
[email protected]
Christian Thomas, MD
Principal Investigator
Lovelace Medical Center - Saint Joseph Square
Albuquerque New Mexico, 87102, United States More Info
Leslie Byatt
Contact
505-925-0366
[email protected]
Bernard Tawfik, MD
Principal Investigator
Presbyterian Kaseman Hospital
Albuquerque New Mexico, 87110, United States More Info
Monique Robertson, RN
Contact
505-559-6100
[email protected]
Bernard Tawfik, MD
Principal Investigator
The University of New Mexico Comprehensive Cancer Center
Albuquerque New Mexico, 87131, United States More Info
Kawryn Gustafson, RN
Contact
505-925-0380
[email protected]
Bernard Tawfik, MD
Principal Investigator
Memorial Medical Center
Las Cruces New Mexico, 88011, United States More Info
Kim Hoffman, RN
Contact
575-556-6545
[email protected]
Bernard Tawfik, MD
Principal Investigator
Presbyterian Rust Medical Center
Rio Rancho New Mexico, 87124, United States More Info
Andrea Yost
Contact
505-253-7878
[email protected]
Bernard Tawfik, MD
Principal Investigator
Northwell Health Monter Cancer Center
Lake Success New York, 11042, United States More Info
Mary Agnes Templeton
Contact
516-734-8979
[email protected]
Marina Frimer, MD
Principal Investigator
Herbert Irving Comprehensive Cancer Center
New York New York, 10032, United States More Info
Kim Roman
Contact
212-342-3970
[email protected]
Richard Carvajal, MD
Principal Investigator
Lineberger Comprehensive Cancer Center
Chapel Hill North Carolina, 27599, United States More Info
Cole Cole
Contact
919-966-4432
[email protected]
Shetal Patel, MD
Principal Investigator
Atrium Health's Levine Cancer Institute
Charlotte North Carolina, 28277, United States More Info
Kelly Bumgarner, RN, CCRP
Contact
704-403-2520
[email protected]
Kathryn F. Mileham, MD, FACP
Principal Investigator
Sanford Health- Bismarck
Bismarck North Dakota, 58501, United States More Info
Peter Kurniali, MD
Contact
701-323-5741
[email protected]
Peter Kurniali, MD
Principal Investigator
Sanford Health- Fargo
Fargo North Dakota, 58122, United States More Info
Anu Gaba, MD
Contact
701-234-6161
[email protected]
Anu Gaba, MD
Principal Investigator
University of Cincinnati Medical Center
Cincinnati Ohio, 45219, United States More Info
Alexander Love
Contact
513-580-2472
[email protected]
Trisha Wise-Draper, MD
Principal Investigator
Kettering Health
Kettering Ohio, 45429, United States More Info
Allison Dymacek, BSN, RN
Contact
937-395-8367
[email protected]
Malek Safa, MD
Principal Investigator
West Chester Hospital
West Chester Ohio, 45069, United States More Info
Alexander Love
Contact
513-580-2472
[email protected]
Trisha Wise-Draper, MD
Principal Investigator
Providence Health & Services
Portland Oregon, 97213, United States More Info
Melissa Pomeroy, RN, BSN, OCN
Contact
503-215-2714
[email protected]
Walter Urba, MD
Principal Investigator
Lehigh Valley Hospital
Allentown Pennsylvania, 18105, United States More Info
Stephanie Couch, BS
Contact
734-712-3671
[email protected]
Tareq Al Baghdadi, MD
Principal Investigator
Fox Chase Cancer Center
Philadelphia Pennsylvania, 19111, United States More Info
Fathima S Sheriff
Contact
215-728-4094
[email protected]
Margaret von Mehren, MD
Principal Investigator
SC Cancer Specialists at St. Joseph's/Candler Bluffton
Bluffton South Carolina, 29910, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
St. Joseph's/Candler Smith
Bluffton South Carolina, 29910, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
Summit Cancer Care at St. Josph's/Candler Bluffton
Bluffton South Carolina, 29910, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
South Carolina Cancer Specialists
Hilton Head Island South Carolina, 29926, United States More Info
Stephanie Smith, RN, MSN, OCN
Contact
912-819-5723
[email protected]
Mark Taylor, MD
Principal Investigator
Sanford Cancer Center Oncology Clinic and Pharmacy
Sioux Falls South Dakota, 57104, United States More Info
Steven Powell, MD
Contact
605-328-5000
[email protected]
Steven Powell, MD
Principal Investigator
Tennessee Oncology - Nashville / Sarah Cannon Research Institute
Nashville Tennessee, 37203, United States More Info
Ethan Trull
Contact
615-329-7274
[email protected]
Meredith McKean, MD, MPH
Principal Investigator
The University of Texas MD Anderson Cancer Center
Houston Texas, 77030, United States More Info
Amanda Eckert, MPH
Contact
713-745-8074
[email protected]
Funda Meric-Bernstam, MD
Principal Investigator
Intermountain Healthcare
Salt Lake City Utah, 84107, United States More Info
Tracy Taylor
Contact
801-507-3953
[email protected]
Angi Kahrs, CCRP
Contact
435-251-4742
[email protected]
Ramya Thota, M.D.
Principal Investigator
Derrick Haslem, M.D.
Principal Investigator
Inova Schar Cancer Institute
Fairfax Virginia, 22042, United States More Info
Lindsey Tishman, MHA, CCRC
Contact
703-970-6488
[email protected]
Timothy Cannon, MD
Principal Investigator
Swedish Cancer Institute
Seattle Washington, 98104, United States More Info
Leah Clemente
Contact
206-386-2227
[email protected]
Philip Gold, MD
Principal Investigator
Aurora Cancer Care - Burlington
Burlington Wisconsin, 53105, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Health Care - Germantown Health Center
Germantown Wisconsin, 53022, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Cancer Care - Grafton
Grafton Wisconsin, 53024, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora BayCare Medical Center
Green Bay Wisconsin, 54311, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Cancer Care - Kenosha South
Kenosha Wisconsin, 53142, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Bay Area Medical Center
Marinette Wisconsin, 54143, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Cancer Care Milwaukee
Milwaukee Wisconsin, 53209, United States More Info
Mary Jo M Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora St. Luke's Medical Center
Milwaukee Wisconsin, 53215, United States More Info
Mary Jo M Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Sinai Medical Center
Milwaukee Wisconsin, 53223, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora West Allis Medical Center
Milwaukee Wisconsin, 53227, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Vince Lombardi Cancer Clinic - Oshkosh
Oshkosh Wisconsin, 54904, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Cancer Care - Racine
Racine Wisconsin, 53406, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Vince Lombardi Cancer Center
Sheboygan Wisconsin, 53081, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Medical Center in Summit
Summit Wisconsin, 53066, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Vince Lombardi Cancer Clinic - Two Rivers
Two Rivers Wisconsin, 54241, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator
Aurora Cancer Care - Milwaukee West
Wauwatosa Wisconsin, 53226, United States More Info
Mary Jo Luser, BSN, RN, OCN
Contact
414-646-9825
[email protected]
Antony Ruggeri, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 2

Estimated Enrollment:

3641

Study ID:

NCT02693535

Recruitment Status:

Recruiting

Sponsor:


American Society of Clinical Oncology

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.